Trend

Last Previous Currency Date Chng
830.79 836.41 USD 25/12/17 -0.67

Terms

Isin LU0133359157
Contract Type Sicav
Currency USD
Class N
Risk Class 5
Assogestioni Category Azionari Salute
Declared Benchmark 100% Nasdaq Biotechnology Net TR Index
Start Date 02/08/22
Advisor Name Rudi Van den Eynde
Fund Asset Under Management 51,1751  at 25/11/28

Performance

Cumulatives
1 month +0.41
Ytd +22.10
1 year +18.40
3 years +34.87
5 years +46.29
Yearly
11/30/2024 +8.68
11/30/2023 +3.06
11/30/2022 +4.13
11/30/2021 +4.97
11/30/2020 +8.65
Rating
N.Av.
Score
N.Av.

Company

Candriam
Serenity Bloc B 19-21, route d�Arlon L-8009 - Strassen
Tel. +352-27975130

Costs

Entrance (ACP) Min: 0,0000 - Max: 0,0000
Management 2
Reimbursement 0%
Administrative 0,4%
Switch 0%
Tunnel 0

Subscription

One Solution
Initial N.Av. USD
Integrative 0,0000 USD
Accumulation Plan
Duration N.Av.
Minimum Payment Unit N.Av.
Initial Payment N.Av.

Costs

Entrance (ACP) Min: 0,0000 - Max: 0,0000
Management 2
Reimbursement 0%
Administrative 0,4%
Switch 0%
Tunnel 0

Performance

Cumulatives
1 day -0.21
1 week -1.67
1 month +0.41
3 months +23.72
6 months +43.21
From the beginning of the year +22.10
1 year +18.40
2 years +36.89
3 years +34.87
4 years +41.94
5 years +46.29
Yearly
11/30/2024 +8.68
11/30/2023 +3.06
11/30/2022 +4.13
11/30/2021 +4.97
11/30/2020 +8.65


Rating
N.Av.
Score
N.Av.

Efficiency Indicators

Sharpe 1 year 0.5446
Benchmark 1 year N.Av.
Sharpe 3 years 0.3279
Benchmark 3 years N.Av.
Sharpe 5 years 0.4923
Benchmark 5 years N.Av.
Sortino 1 year 0.8926
Benchmark 1 year N.Av.
Sortino 3 years 0.5283
Benchmark 3 years N.Av.
Sortino 5 years 0.8121
Benchmark 5 years N.Av.

Absolute

Standard Volatility
1 year +23.04
3 years +17.53
5 years +16.60
Negative Volatility
1 year +14.18
3 years +10.84
5 years +10.01

Benchmark

Standard Volatility
1 year N.Av.
3 years N.Av.
5 years N.Av.
Negative Volatility
1 year N.Av.
3 years N.Av.
5 years N.Av.
Updated Monthly - 25/11/28

Relative

Sharpe 0.3279
Sortino 0.5283
Bull Market +9.59
Bear Market -3.84
Benchmark N.Av.
Benchmark N.Av.
Benchmark N.Av.
Benchmark N.Av.
Three years data
Risk Class 5

General

  1 year 17,746 3 years 15,635 5 years 13,875
  Pos. Chng % Pos. Chng % Pos. Chng %
Performance
1 year 17,746
11,740
  
+20.08
3 years 15,635
3,394
  
+34.46
5 years 13,875
2,316
  
+56.35
Performance
11,740 +20.08 3,394 +34.46 2,316 +56.35
Total Volatility
1 year 17,746
17,795
  
+23.04
3 years 15,635
14,683
  
+17.53
5 years 13,875
12,639
  
+16.60
Total Volatility
17,795 +23.04 14,683 +17.53 12,639 +16.60
Negative Volatility
1 year 17,746
16,380
  
+14.18
3 years 15,635
8,704
  
+10.84
5 years 13,875
10,647
  
+10.01
Negative Volatility
16,380 +14.18 8,704 +10.84 10,647 +10.01
Sharpe Index
1 year 17,746
15,293
  
+0.54
3 years 15,635
5,688
  
+0.33
5 years 13,875
4,141
  
+0.49
Sharpe Index
15,293 +0.54 5,688 +0.33 4,141 +0.49
Sortino Index
1 year 17,746
14,501
  
+0.89
3 years 15,635
2,291
  
+0.53
5 years 13,875
2,759
  
+0.81
Sortino Index
14,501 +0.89 2,291 +0.53 4,141 +0.81

By Category

  1 year 17,746 3 years 15,635 5 years 13,875
  Pos. Chng % Pos. Chng % Pos. Chng %
Performance
1 year 17,746
60
  
+20.08
3 years 15,635
39
  
+34.46
5 years 13,875
41
  
+56.35
Performance
60 +20.08 39 +34.46 41 +56.35
Total Volatility
1 year 17,746
45
  
+23.04
3 years 15,635
50
  
+17.53
5 years 13,875
46
  
+16.60
Total Volatility
45 +23.04 50 +17.53 46 +16.60
Negative Volatility
1 year 17,746
31
  
+14.18
3 years 15,635
43
  
+10.84
5 years 13,875
49
  
+10.01
Negative Volatility
31 +14.18 43 +10.84 49 +10.01
Sharpe Index
1 year 17,746
62
  
+0.54
3 years 15,635
50
  
+0.33
5 years 13,875
48
  
+0.49
Sharpe Index
62 +0.54 50 +0.33 48 +0.49
Sortino Index
1 year 17,746
61
  
+0.89
3 years 15,635
41
  
+0.53
5 years 13,875
43
  
+0.81
Sortino Index
61 +0.89 41 +0.53 43 +0.81

Foreign Funds - Candriam Eq. L Biotechnology N $: Performance, Terms, Fees, Risk, Rating


The Exchange accepts no responsability for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.


You will be redirected in five seconds.